Alexis Kim, MD
Endocrinology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kim’s office at (408) 739-6000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G81813 · Current
Licensed to practise in California · since 1995 · expires 2028-09-30 · Vanderbilt University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$1,915
Medicare paid this office $1,915 for 25 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Insertion of needle into vein for collection of blood sample | 20 | $225 | $9 |
| Blood test, comprehensive group of blood chemicals | 18 | $197 | $10 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 14 | $114 | $8 |
Who their Medicare patients are
25 Original Medicare patients in 2024. Average age 76 · Health risk score 1.60. Above the middle of the specialty; the typical endocrinology clinician is at 1.46.
Conditions among them: High blood pressure 75% · Coronary heart disease 56% · Atrial fibrillation 44%.
The office billed $10,262, Medicare allowed $1,980 and paid $1,915; for 133 services of 29 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 25 | 133 | 76 | 1.60 | $10,262 | $1,915 |
| 2023 | 18 | 77 | 76 | 1.03 | $5,469 | $963 |
| 2022 | 28 | 117 | 78 | 1.15 | $8,189 | $1,296 |
| 2021 | 31 | 130 | 81 | 1.50 | $9,350 | $1,633 |
| 2020 | 31 | 222 | 80 | 1.41 | $23,151 | $5,044 |
| 2019 | 14 | 68 | 76 | 1.25 | $4,093 | $804 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Insertion of needle into vein for collection of blood sample | 17 | $151 | $8 |
2022: 3 services
| Blood test, comprehensive group of blood chemicals | 16 | $165 | $10 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 15 | $121 | $8 |
| Insertion of needle into vein for collection of blood sample | 26 | $79 | $3 |
2021: 4 services
| Natriuretic peptide (heart and blood vessel protein) level | 18 | $707 | $39 |
| Blood test, comprehensive group of blood chemicals | 17 | $180 | $11 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 17 | $140 | $8 |
| Insertion of needle into vein for collection of blood sample | 29 | $93 | $3 |
2020: 5 services
| Natriuretic peptide (heart and blood vessel protein) level | 11 | $507 | $39 |
| Blood test, comprehensive group of blood chemicals | 15 | $178 | $10 |
| Blood test, lipids (cholesterol and triglycerides) | 12 | $173 | $13 |
| Insertion of needle into vein for collection of blood sample | 29 | $164 | $3 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 14 | $124 | $8 |
2019: 1 service
| Insertion of needle into vein for collection of blood sample | 13 | $44 | $3 |
Money from drug and device companies
$272 in 2025
| 2025 | 4 | 6 | None | $272 |
| 2024 | 2 | 2 | None | $134 |
| 2023 | 2 | 3 | None | $175 |
| 2022 | 1 | 1 | None | $139 |
| 2021 | 1 | 1 | None | $74 |
| 2020 | 1 | 1 | None | $118 |
| 2019 | 2 | 2 | None | $229 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| EMD Serono | None | $122 | 1 payment
|
| CooperSurgical | Origio Sequential Fert | $63 | 1 payment
|
| Organon | Nexplanon | $47 | 2 payments
|
| Ferring Pharmaceuticals | Menopur | $39 | 2 payments
|
See all 6 published payments
| EMD Serono | Meals · 2025-10-09 | None | $122 |
| CooperSurgical | Meals · 2025-06-20 | Origio Sequential Fert | $63 |
| Organon | Meals · 2025-05-21 | Nexplanon | $27 |
| Ferring Pharmaceuticals | Education · 2025-05-07 | Menopur | $20 |
| Ferring Pharmaceuticals | Education · 2025-05-07 | Menopur | $20 |
| Organon | Meals · 2025-03-26 | None | $20 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $134
| EMD Serono | None | $123 | 1 payment
|
| Organon | Follistim Aq | $11 | 1 payment
|
2023: $175
| EMD Serono | None | $146 | 1 payment
|
| Organon | Ganirelix Acetate | $29 | 2 payments
|
2022: $139
| EMD Serono | None | $139 | 1 payment
|
2021: $74
| CooperSurgical | Non-Gyn Products | $74 | 1 payment
|
2020: $118
| Merck Sharp & Dohme | Follistim Aq | $118 | 1 payment
|
2019: $229
| EMD Serono | None | $125 | 1 payment
|
| Merck Sharp & Dohme | Follistim Aq | $104 | 1 payment
|
Professional record
- NPI
- 1053411967
- Licence
- CA G81813California G81813: Current · expires 2028-09-30
- Trained
- Vanderbilt University School of Medicine, 1989
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207VE0102X (207VE0102X)
- Mailing address
- 2350 W El Camino Real, Mountain View, CA, 94040
- NPI first listed
- 2006-09-22
- NPI last updated
- 2013-08-01
This is when the NPI record was last certified, not a medical board exam.